Evidence map›Paper›PMID 29189931›Full record

ArticleEuropean radiology2018

Preoperative sentinel lymph node localization in vulvar cancer: preliminary experience with inguinal intradermal contrast-enhanced ultrasound.

O Lahtinen, M Eloranta, M Anttila, H Kärkkäinen, R Sironen, R Vanninen, S Rautiainen

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Detection of sentinel lymph node in vulvar cancer usingArchives of gynecology and obstetrics · 2023
    Pooled it
  2. Article
  3. Article
  4. Detection of lymph node metastases in penile cancer.Translational andrology and urology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

O LahtinenDiagnostic Imaging Centre, Department of Clinical Radiology, Kuopio University Hospital, PO Box 100, FI-70029, Kuopio, Finland. olli.lahtinen@kuh.fi.
M ElorantaDepartment of Gynaecology and Obstetrics, Kuopio University Hospital, Kuopio, Finland.
M AnttilaDepartment of Gynaecology and Obstetrics, Kuopio University Hospital, Kuopio, Finland.
H KärkkäinenDepartment of Gynaecology and Obstetrics, Kuopio University Hospital, Kuopio, Finland.
R SironenCancer Center of Eastern Finland, Kuopio, Finland.
R VanninenDiagnostic Imaging Centre, Department of Clinical Radiology, Kuopio University Hospital, PO Box 100, FI-70029, Kuopio, Finland.
S RautiainenDiagnostic Imaging Centre, Department of Clinical Radiology, Kuopio University Hospital, PO Box 100, FI-70029, Kuopio, Finland.
Kuopio University Hospital · FIUniversity of Eastern Finland · FI

Funding

Kuopion Yliopistollinen Sairaala 5063542
6 · The paper itself

Abstract

objectiveTo evaluate the feasibility and diagnostic performance of intradermal contrast-enhanced ultrasound (CEUS) sentinel lymph node (SLN) procedure in vulvar cancer.

methodsTwelve consecutive patients with vulvar cancer underwent preoperatively inguinal CEUS SLN examination and guide wire marking of the enhanced lymph nodes. Altogether, 20 groins were examined with CEUS contrast agent injections including 8 bilateral groins due to midline tumours. One groin was excluded due to previous inguinal surgery. The results of the CEUS examinations were compared to conventional SLN biopsy using radiocolloid scintigraphy and/or methylene blue dye and final postoperative histopathology.

resultsThe inguinal sentinel CEUS procedure had a technical success rate of 94.7% (18/19 injections) for identifying a potential inguinal SLN. Conventional SLN biopsy using lymphoscintigraphy and/or methylene blue dye was successfully performed in 16 groins. Compared to conventional SLN biopsy, the overall sensitivity was 81.2% (13/16 injections). Additionally, CEUS detected enhancing SLNs in two cases when traditional SLN procedure failed to do so. All metastatic SLNs (n = 5) were correctly identified by CEUS procedure.

conclusionsIntradermal CEUS SLN localization can be applied in the inguinal lymphatic region in patients with vulvar cancer. Further studies are needed to verify the clinical value of this method. KEY POINTS: • CEUS is a feasible method for inguinal SLN detection in vulvar cancer • All metastatic inguinal SLNs were identified by CEUS procedure • Further studies are needed to verify the clinical value of this method.

Indexed as

AgedAged, 80 and overCarcinoma, Squamous CellContrast MediaFeasibility StudiesFemaleGroinHumansImage-Guided BiopsyLymphatic MetastasisMiddle AgedPreoperative CareSentinel Lymph NodeSentinel Lymph Node BiopsyUltrasonographyVulvar NeoplasmsContrast MediaContrast-enhanced ultrasoundGuide-wire markingInguinal lymph nodeSentinel lymph nodeVulvar cancer

Identifiers

PMID29189931
OpenAlexW2772673762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.